869 Venetoclax, a specific BCL-2 inhibitor, modulates CAR T cells genetically and functionally during production and augments their anti-tumor response

• Jun Huang,
• James LaBelle,
• Ryan Park,
• Nada S Aboelella,
• Tony Pan,
• Erting Tang

Affiliations

Jun Huang

University of Chicago, Chicago, IL, USA

James LaBelle

University of Chicago, Chicago, IL, USA

Ryan Park

University of Chicago, Chicago, IL, USA

Nada S Aboelella

University of Chicago, Chicago, IL, USA

Tony Pan

University of Chicago, Chicago, IL, USA

Erting Tang

University of Chicago, Chicago, IL, USA